|Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial|
M Scorsetti, S Arcangeli, A Tozzi, T Comito, F Alongi, P Navarria, ...
International Journal of Radiation Oncology* Biology* Physics 86 (2), 336-342, 2013
|Review and uses of stereotactic body radiation therapy for oligometastases|
F Alongi, S Arcangeli, AR Filippi, U Ricardi, M Scorsetti
The oncologist 17 (8), 1100, 2012
|Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non …|
P Navarria, AM Ascolese, P Mancosu, F Alongi, E Clerici, A Tozzi, C Iftode, ...
Radiotherapy and Oncology 107 (3), 414-418, 2013
|IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy|
F Alongi, C Fiorino, C Cozzarini, S Broggi, L Perna, GM Cattaneo, ...
Radiotherapy and Oncology 93 (2), 207-212, 2009
|Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments|
M Scorsetti, F Alongi, S Castiglioni, A Clivio, A Fogliata, F Lobefalo, ...
Radiation oncology 6 (1), 1-8, 2011
|MR-guidance in clinical reality: current treatment challenges and future perspectives|
S Corradini, F Alongi, N Andratschke, C Belka, L Boldrini, F Cellini, ...
Radiation Oncology 14 (1), 1-12, 2019
|Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study|
F Alongi, L Cozzi, S Arcangeli, C Iftode, T Comito, E Villa, F Lobefalo, ...
Radiation Oncology 8 (1), 1-8, 2013
|Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer|
C Cozzarini, C Fiorino, N Di Muzio, F Alongi, S Broggi, M Cattaneo, ...
Radiotherapy and oncology 84 (2), 164-170, 2007
|Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study|
L Triggiani, F Alongi, M Buglione, B Detti, R Santoni, A Bruni, ...
British journal of cancer 116 (12), 1520-1525, 2017
|SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience|
A Tozzi, T Comito, F Alongi, P Navarria, C Iftode, P Mancosu, G Reggiori, ...
Radiation Oncology 8 (1), 1-8, 2013
|Need for high radiation dose (≥ 70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients|
C Cozzarini, F Montorsi, C Fiorino, F Alongi, A Bolognesi, LF Da Pozzo, ...
International Journal of Radiation Oncology* Biology* Physics 75 (4), 966-974, 2009
|Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments|
P Navarria, AM Ascolese, S Tomatis, L Cozzi, F De Rose, P Mancosu, ...
Radiation Oncology 9 (1), 1-8, 2014
|Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of …|
M Scorsetti, F Alongi, A Fogliata, S Pentimalli, P Navarria, F Lobefalo, ...
Radiation oncology 7 (1), 1-8, 2012
|Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy|
C Fiorino, N Di Muzio, S Broggi, C Cozzarini, E Maggiulli, F Alongi, ...
International Journal of Radiation Oncology* Biology* Physics 71 (2), 611-617, 2008
|Dose–volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer|
C Fiorino, F Alongi, L Perna, S Broggi, GM Cattaneo, C Cozzarini, ...
International Journal of Radiation Oncology* Biology* Physics 75 (1), 29-35, 2009
|Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients|
M Scorsetti, F Alongi, AR Filippi, S Pentimalli, P Navarria, E Clerici, ...
Acta Oncologica 51 (5), 618-623, 2012
|Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients|
C Cozzarini, C Fiorino, LF Da Pozzo, F Alongi, G Berardi, A Bolognesi, ...
International Journal of Radiation Oncology* Biology* Physics 82 (1), 191-199, 2012
|Neuroendocrine carcinoma of the breast: current evidence and future perspectives|
A Inno, G Bogina, M Turazza, L Bortesi, S Duranti, A Massocco, ...
The oncologist 21 (1), 28, 2016
|Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique|
R Ruggieri, S Naccarato, R Mazzola, F Ricchetti, S Corradini, A Fiorentino, ...
Radiation Oncology 13 (1), 1-9, 2018
|Phase I–II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer|
N Di Muzio, C Fiorino, C Cozzarini, F Alongi, S Broggi, P Mangili, ...
International Journal of Radiation Oncology* Biology* Physics 74 (2), 392-398, 2009